Strategy of STAT3β cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer

Gene Therapy

Volumn 22, Issue 12, 2015, Pages 977-983

  Dang, W ^a   Tang, H ^a   Cao, H ^a   Wang, L ^a   Zhang, X ^a   Tian, W ^a   Pang, X ^a   Li, K ^a   Chen, T ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; STAT3 PROTEIN; STAT3BETA PROTEIN; UNCLASSIFIED DRUG; RECOMBINANT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GENE THERAPY; CANCER GROWTH; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR VOLUME; ADENOVIRIDAE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL MOTION; COCULTURE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; MACROPHAGE; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; FEMALE; GENE EXPRESSION; HEK293 CELLS; HUMANS; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84949096316     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2015.70     Document Type: Article

References (29)

1. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19: 1423-1437.
2. Zhang Y, Yang P, Wang XF. Microenvironmental regulation of cancer metastasis by miRNAs. Trends Cell Biol 2014; 24: 153-160.
3. Sounni NE, Noel A. Targeting the tumor microenvironment for cancer therapy. Clin Chem 2013; 59: 85-93.
4. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 2013; 496: 445-455.
5. De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013; 23: 277-286.
6. Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers 2014; 6: 1670-1690.
7. He KF, Zhang L, Huang CF, Ma SR, Wang YF, Wang WM et al. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. Biomed Res Int 2014; 2014: 838632.
8. Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L et al. Tumor-associated microglia/ macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J Immunol 2012; 189: 444-453.
9. Su S, Liu Q, Chen J, Chen F, He C, Huang D et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 2014; 25: 605-620.
10. Chen J, Yao Y, Gong C, Yu F, Su S, Liu B et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 2011; 19: 541-555.
11. Fofaria NM, Srivastava SK. Critical role of STAT3 in melanoma metastasis through anoikis resistance. Oncotarget 2014; 5: 7051-7064.
12. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9: 798-809.
13. Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007; 7: 41-51.
14. Zhang X, Tian W, Cai X, Wang X, Dang W, Tang H et al. Hydrazinocurcumin encapsuled nanoparticles "re-educate" tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression. PLoS One 2013; 8: e65896.
15. Fujiwara Y, Takeya M, Komohara Y. A novel strategy for inducing the antitumor effects of triterpenoid compounds: blocking the protumoral functions of tumorassociated macrophages via STAT3 inhibition. Biomed Res Int 2014; 2014: 348539.
16. Niu G, Shain KH, Huang M, Ravi R, Bedi A, Dalton WS et al. Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res 2001; 61: 3276-3280.
17. Xu G, Zhang C, Zhang J. Dominant negative STAT3 suppresses the growth and invasion capability of human lung cancer cells. Mol Med Rep 2009; 2: 819-824.
18. Zammarchi F, de Stanchina E, Bournazou E, Supakorndej T, Martires K, Riedel E et al. Antitumorigenic potential of STAT3 alternative splicing modulation. Proc Natl Acad Sci USA 2011; 108: 17779-17784.
19. Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JA, Lammers JW et al. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 1996; 271: 13221-13227.
20. Kang WS, Kwon JS, Kim HB, Jeong HY, Kang HJ, Jeong MH et al. A macrophagespecific synthetic promoter for therapeutic application of adiponectin. Gene Therapy 2014; 21: 353-362.
21. Levin MC, Lidberg U, Jirholt P, Adiels M, Wramstedt A, Gustafsson K et al. Evaluation of macrophage-specific promoters using lentiviral delivery in mice. Gene Therapy 2012; 19: 1041-1047.
22. Wen YA, Yu XL, Xia QF, Cen D, Liu JB, Tu ZG. Macrophage-specific overexpression of antimicrobial peptide PR-39 inhibits intracellular growth of Salmonella enterica serovar Typhimurium in macrophage cells. Int J Antimicrob Agents 2009; 34: 315-321.
23. Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2007; 2: 1236-1247.
24. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C et al. Targeting tumorassociated macrophages as a novel strategy against breast cancer. J Clin Invest 2006; 116: 2132-2141.
25. Herrmann A, Kortylewski M, Kujawski M, Zhang C, Reckamp K, Armstrong B et al. Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells. Cancer Res 2010; 70: 7455-7464.
26. Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C et al. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 2012; 21: 642-654.
27. Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001; 20: 7925-7934.
28. Gough PJ, Gordon S, Greaves DR. The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology 2001; 103: 351-361.
29. He W, Qiang M, Ma W, Valente AJ, Quinones MP, Wang W et al. Development of a synthetic promoter for macrophage gene therapy. Hum Gene Ther 2006; 17: 949-959.